Active Cells, Biochemistry & Physiology Genetics & Molecular Biology

Ringing the changes: how bacterial enzymes convert ribosomally-synthesised peptides into antibiotics

In plain English

AI plain-English summary

Bacterial YcaO enzymes are being turned into molecular assembly lines to produce new antibiotics. These enzymes are essential for building several classes of natural antibiotics, but scientists do not yet understand how they work or how their activity is coordinated inside multi-protein complexes. Without this knowledge, researchers cannot reliably repurpose YcaOs to create artificial peptide drugs. This project will use cryo-electron microscopy and X-ray crystallography to capture snapshots of YcaO enzymes trapped at different stages of their catalytic cycle. The researcher will also discover new YcaO variants to expand the known chemical reactions they can perform. Because YcaOs are promiscuous—they accept many different peptide sequences—the team will co-express randomised precursor genes alongside modification systems to generate large libraries of potential antibiotics. These will be screened using a high-throughput platform where nano-sized hydrogel beads, each containing a producer and a reporter bacterial strain, are sorted by fluorescence-activated cell sorting. This is fundamental science. It will not produce a market-ready drug tomorrow. But understanding how YcaOs build antibiotic scaffolds could eventually enable the rational design of entirely new classes of antimicrobials, addressing the growing crisis of drug-resistant infections.

View original technical description
The project aims to investigate the mechanism of peptide transformations carried out by YcaO enzymes and to use this knowledge to create novel antimicrobials. Bacterial YcaO proteins are essential for the biosynthesis of multiple classes of peptide natural products through their ability to introduce important structural modifications including heterocycles, macrocycles, and thioamides. YcaO repurposing and swapping between different pathways offers exciting possibilities to create novel artificial peptides bearing such modifications. Despite much recent progress, we still do not really understand how these proteins work, and how their activities are coordinated within multisubunit enzyme complexes. I will use cryo-EM in combination with X-ray crystallography to solve the structures of YcaOs within their native complex assemblies trapped at different catalytic stages. In parallel, I will discover and characterise new YcaO proteins to further expand their known catalytic repertoire. Finally, the promiscuity of YcaOs allows for the production of large genetically encoded peptide antibiotic libraries. I will generate these by co-expressing randomised precursor genes along with modification systems. A high-throughput fluorescence-based version of a Waksman platform will be used for screening, where nano-sized “Petri dishes” (hydrogel beads) will be inoculated with both producer and reporter strains and sorted by FACS.

View the original record at the funder ↗

Researchers

Dale Sanders (EPMC Awardee)Dmitry Ghilarov (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Exploiting a novel peptide cyclase to make new antibiotics
Tackling antimicrobial resistance (AMR) with protein engineering to produce novel yanuthone-based antimicrobial agents
Catching antibiotic factories in action
Enzymology and engineering of the biosynthesis of polyether antibiotics
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria

Original classification

Residual Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.